Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jun 21, 2022; 28(23): 2609-2624
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2609
Table 1 Magnetic resonance imaging sequences and data acquisition parameters
Parameter
Magnetic resonance imaging sequences
T2 FSE sagittal
T2 FSE axial
T2 FSE coronal
T1 FSE axial
DWI axial
T1 + GD axial
T1 + GD coronal
T1 + GD coronal
Repetition time in ms5325989075098507750435295265
Echo time in ms102102102MinMinMinMinMin
Slices, n3040304040404030
FOV2420202020202024
Slices thickness in mm44444444
Broadband in Hz/Px62.562.55062.5-505050
Phase38438441638460320320320
Acquisition time in min:s2:353:082:453:535:182:312:162:02
Table 2 Clinical and pathological characteristics of the patients’ studies
Characteristics
n (%)
Sex
Female23 (48)
Male25 (52)
RECIST 1.1
Partial response22 (46)
Stable disease13 (27)
Progressive disease13 (27)
Ryan’s classification
018 (38)
110 (21)
29 (19)
311 (22)
Treatment response
Complete responders after nCRT18 (38)
Non-responders’ patients after nCRT30 (62)
Tumor location
Upper third7 (15)
Middle third14 (29)
Lower third 20 (41)
Diffuse 7 (15)
ypT stage
T04 (8)
T1s4 (8)
T1a2 (4)
T28 (17)
T320 (42)
T4b10 (21)
ypN stage
N020 (42)
N1a14 (29)
Nic14 (29)
Degree of differentiation
Well-differentiated adenocarcinoma6 (13)
Moderately differentiated adenocarcinoma35 (73)
Poorly differentiated adenocarcinoma7 (14)
Surgical approach
Low anterior resection16 (33)
Intersphincteric resection26 (54)
Abdominoperineal resection6 (13)
Table 3 Median and interquartile range of pre- and post-neoadjuvant chemoradiation therapy parameters, as well as of changes between pre- and post-treatment values

Responders
Non-responders
P value
Pre-nCRT parameters
pre-nCRT ADCmean0.75 (0.60-0.90)0.85 (0.70-0.90)0.146
10th percentile0.20 (0.17-0.23)0.20 (0.17-0.26)0.812
25th percentile0.32 (0.29-0.35)0.32 (0.23-0.41)1.000
50th percentile0.40 (0.35-0.40)0.40 (0.30-0.50)0.698
75th percentile0.56 (0.47-0.58)0.57 (0.45-0.63)0.391
90th percentile0.71 (0.55-0.77)0.76 (0.50-0.80)0.556
Skewness1.10 (0.90-1.14)1.19 (0.88-1.37)0.135
Kurtosis0.89 (0.83-0.92)0.92 (0.83-0.95)0.296
ROI ADCmean0.92 (0.80-1.20)0.91 (0.83-0.93)0.562
Post- nCRT parameters
post- nCRT ADCmean1.20 (0.98-1.52)1.10 (0.90-1.30)0.065
10th percentile0.36 (0.30–0.37)0.32 (0.31–0.34)0.0361
25th percentile0.41 (0.40-0.52)0.42 (0.41-0.50)0.476
50th percentile0.66 (0.56-0.70)0.65 (0.51-0.66)0.127
75th percentile0.71 (0.67-0.80)0.70 (0.66-0.75)0.050
90th percentile0.89 (0.80-0.95)0.80 (0.79-0.89)0.105
Skewness0.92 (0.60–1.14)2.00 (1.15–2.67)< 0.0011
Kurtosis0.65 (0.59–0.72)0.90 (0.80–0.90)< 0.0011
ROI ADCmean2.50 (1.50-2.70)2.00 (1.80-2.30)0.056
Changes between pre-treatment and post-treatment
∆%ADCmean57% (14%–103%)27% (0%–59%)0.0321
∆%ADC10th86% (37%–118%)48% (11%–88%)0.0201
∆%ADC25th39% (19%-57%)22% (0%-58%)0.905
∆%ADC50th70% (31%-86%)31% (2%-65%)0.067
∆%ADC75th40% (20%-61%)37% (0%-57%)0.288
∆%ADC90th27% (11%-58%)9% (7%-119%)0.061
∆skewness–0.20 (–0.40–0.00)0.49 (0.10–0.50)< 0.0011
∆%kurtosis41% (18%–54%)2.5% (1.4%–5.9%)< 0.0011
ROI ∆%ADCmean55% (48%–60%)23% (15%–30%)0.0201
Table 4 Diagnostic performance of the best magnetic resonance imaging histogram derived parameters to detect responder patients

Cutoff
Sensitivity
Specificity
PPV
NPV
Accuracy
AUC (95%CI)
∆%kurtosis11.85%94.4%96.7%94.4%96.7%96.0%0.991 (0.925-1.000)
Post-nCRT kurtosis0.7893.3%99.0%90%99.0%96.0%0.985 (0.957-1.000)
∆skewness0.1666.7%99.0%64.3%99.0%79.2%0.885 (0.795-0.975)
Post-nCRT skewness1.5963.3%99.0%62.0%99.0%77.1%0.815 (0.795-0.634)
Post-nCRT ADC10th0.34×10-3 mm2/s66.7%73.3%60.0%79.0%71.0%0.681 (0.509-0.852)
∆%ADCmean56.00%56.0%77.0%56.0%73.3%66.7%0.686 (0.500-0.820
∆%ADC10th74.21%61.1%70.0%55.0%75.0%66.7%0.589 (0.483-0.815)
ROI ∆%ADCmean55.00%61.0%69.0%52.0%72.0%65.3%0.583 (0.425-0.715)
Table 5 Diagnostic odds ratios of magnetic resonance imaging parameters in differentiating respond and non- respond patients in locally advanced rectal cancer

Diagnostic odds ratio
95%CI
∆%kurtosis376.0228.9-842.1
Post-nCRT kurtosis 375.3225.7-887.7
∆skewness192.269.0-253.3
Post-nCRT skewness168.654.0-251.7
Post-nCRT ADC10th5.481.0-19.6
∆%ADCmean4.261.0-14.4
∆%ADC10th3.651.0-12.5
ROI ∆%ADCmean3.471.0-11.2
Table 6 Intraobserver variability

ICC
95%CI
Basal
Test1 and test2, reader1ROI ADCmean0.8500.742–0.800
Test1 and test2, reader2ROI ADCmean0.8900.850-0.820
After treatment
Test1 and test2, reader1ROI ADCmean0.8000.750-0.819
Test1 and test2, reader2ROI ADCmean0.8230.800-0.850
Basal
Test1 and test2, reader1ADCmean0.8500.756-0.920
Test1 and test2, reader2ADCmean0.7770.745-0.812
After treatment
Test1 and test2, reader1ADCmean0.8450.830-0.850
Test1 and test2, reader2ADCmean0.8230.800-0.833
Basal
Test1 and test2, reader110th percentile0.8200.880-0.950
Test1 and test2, reader210th percentile0.8800.800-0.920
After treatment
Test1 and test2, reader110th percentile0.7800.740-0.853
Test1 and test2, reader210th percentile0.8530.723-0.901
Basal
Test1 and test2, reader125th percentile0.8030.800-0.922
Test1 and test2, reader225th percentile0.8630.801-0.895
After treatment
Test1 and test2, reader125th percentile0.7880.750-0.837
Test1 and test2, reader225th percentile0.8200.780-0.846
Basal
Test1 and test2, reader150th percentile0.8500.840-0.920
Test1 and test2, reader250th percentile0.8450.790-0.860
After treatment
Test1 and test2, reader150th percentile0.8210.800-0.913
Test1 and test2, reader250th percentile0.8330.800-0.897
Basal
Test1 and test2, reader175th percentile0.8210.790-0.860
Test1 and test2, reader275th percentile0.8590.820-0.920
After treatment
Test1 and test2, reader175th percentile0.8510.790-0.880
Test1 and test2, reader275th percentile0.8370.791-0.856
Basal
Test1 and test2, reader190th percentile0.8500.820-0.890
Test1 and test2, reader290th percentile0.8800.850-0.960
After treatment
Test1 and test2, reader190th percentile0.8310.800-0.902
Test1 and test2, reader290th percentile0.9010.850-0.975
Basal
Test1 and test2, reader1Skewness0.9200.900-0.940
Test1 and test2, reader2Skewness0.9010.880-0.923
After treatment
Test1 and test2, reader1Skewness0.9310.920-0.950
Test1 and test2, reader2Skewness0.8890.877-0.910
Basal
Test1 and test2, reader1Kurtosis0.9200.890-0.950
Test1 and test2, reader2Kurtosis0.9100.850-0.960
After treatment
Test1 and test2, reader1Kurtosis0.8900.850-0.960
Test1 and test2, reader2Kurtosis0.8800.840-0.982
Table 7 Interobserver variability (intraclass correlation coefficient and 95% confidence intervals)
Pre-treatment
Reader one vs reader two
Post-treatment
Reader one vs reader two
ROI ADCmean0.985 (1.900-0.999)ROI ADCmean0.889 (0.850-0.950)
ADCmean0.989 (0.980–0.994)ADCmean0.990 (0.985-0.995)
10th percentile0.972 (0.951–0.984)10th percentile0.992 (0.986–0.996)
25th percentile0.970 (0.947–0.983)25th percentile0.950 (0.940-0.982)
50th percentile0.986 (0.976–0.992)50th percentile0.987 (0.945-0.995)
75th percentile0.989 (0.980–0.994)75th percentile0.990 (0.982–0.994)
90th percentile0.989 (0.980–0.994)90th percentile0.972 (0.987–0.996)
Skewness0.990 (0.982–0.994)Skewness0.993 (0.987–0.996)
Kurtosis0.992 (0.986–0.995)Kurtosis0.972 (0.951–0.984)